195 related articles for article (PubMed ID: 19373907)
1. Implications of the proposed thyroid fine-needle aspiration category of "follicular lesion of undetermined significance": A five-year multi-institutional analysis.
Layfield LJ; Morton MJ; Cramer HM; Hirschowitz S
Diagn Cytopathol; 2009 Oct; 37(10):710-4. PubMed ID: 19373907
[TBL] [Abstract][Full Text] [Related]
2. Fine-needle aspiration of follicular patterned lesions of the thyroid: Diagnosis, management, and follow-up according to National Cancer Institute (NCI) recommendations.
Faquin WC; Baloch ZW
Diagn Cytopathol; 2010 Oct; 38(10):731-9. PubMed ID: 20049964
[TBL] [Abstract][Full Text] [Related]
3. Clinical significance of distinguishing between follicular lesion and follicular neoplasm in thyroid fine-needle aspiration biopsy.
Williams MD; Suliburk JW; Staerkel GA; Busaidy NL; Clayman GL; Evans DB; Perrier ND
Ann Surg Oncol; 2009 Nov; 16(11):3146-53. PubMed ID: 19727961
[TBL] [Abstract][Full Text] [Related]
4. Reproducibility of atypia of undetermined significance/follicular lesion of undetermined significance category using the bethesda system for reporting thyroid cytology when reviewing slides from different institutions: A study of interobserver variability among cytopathologists.
Padmanabhan V; Marshall CB; Akdas Barkan G; Ghofrani M; Laser A; Tolgay Ocal I; David Sturgis C; Souers R; Kurtycz DF
Diagn Cytopathol; 2017 May; 45(5):399-405. PubMed ID: 28217980
[TBL] [Abstract][Full Text] [Related]
5. The prediction of malignant risk in the category "atypia of undetermined significance/follicular lesion of undetermined significance" of the Bethesda System for Reporting Thyroid Cytopathology using subcategorization and BRAF mutation results.
Hyeon J; Ahn S; Shin JH; Oh YL
Cancer Cytopathol; 2014 May; 122(5):368-76. PubMed ID: 24591408
[TBL] [Abstract][Full Text] [Related]
6. Evidence-based evaluation of the risks of malignancy predicted by thyroid fine-needle aspiration biopsies.
Marchevsky AM; Walts AE; Bose S; Gupta R; Fan X; Frishberg D; Scharre K; Zhai J
Diagn Cytopathol; 2010 Apr; 38(4):252-9. PubMed ID: 19813257
[TBL] [Abstract][Full Text] [Related]
7. The impact of atypia/follicular lesion of undetermined significance and repeat fine-needle aspiration: 5 years before and after implementation of the Bethesda System.
Sullivan PS; Hirschowitz SL; Fung PC; Apple SK
Cancer Cytopathol; 2014 Dec; 122(12):866-72. PubMed ID: 25078420
[TBL] [Abstract][Full Text] [Related]
8. Fine-needle aspiration of follicular patterned lesions of the thyroid: diagnosis, management, and follow-up according to thyroid Bethesda system.
Ustün H; Astarcı HM; Altunkaya C; Yılmaz S; Barın A; Ekici S; Caydere M
Acta Cytol; 2012; 56(4):361-9. PubMed ID: 22846585
[TBL] [Abstract][Full Text] [Related]
9. The indeterminate thyroid fine-needle aspiration: experience from an academic center using terminology similar to that proposed in the 2007 National Cancer Institute Thyroid Fine Needle Aspiration State of the Science Conference.
Nayar R; Ivanovic M
Cancer; 2009 Jun; 117(3):195-202. PubMed ID: 19382174
[TBL] [Abstract][Full Text] [Related]
10. Follicular lesion of undetermined significance in thyroid FNA revisited.
Walts AE; Mirocha J; Bose S
Diagn Cytopathol; 2014 Jan; 42(1):18-22. PubMed ID: 23894017
[TBL] [Abstract][Full Text] [Related]
11. Malignancy risk for fine-needle aspiration of thyroid lesions according to the Bethesda System for Reporting Thyroid Cytopathology.
Jo VY; Stelow EB; Dustin SM; Hanley KZ
Am J Clin Pathol; 2010 Sep; 134(3):450-6. PubMed ID: 20716802
[TBL] [Abstract][Full Text] [Related]
12. The use of the Bethesda terminology in thyroid fine-needle aspiration results in a lower rate of surgery for nonmalignant nodules: a report from a reference center in Turkey.
Ozluk Y; Pehlivan E; Gulluoglu MG; Poyanli A; Salmaslioglu A; Colak N; Kapran Y; Yilmazbayhan D
Int J Surg Pathol; 2011 Dec; 19(6):761-71. PubMed ID: 21791482
[TBL] [Abstract][Full Text] [Related]
13. Thyroid follicular lesion of undetermined significance: Evaluation of the risk of malignancy using the two-tier sub-classification.
Horne MJ; Chhieng DC; Theoharis C; Schofield K; Kowalski D; Prasad ML; Hammers L; Udelsman R; Adeniran AJ
Diagn Cytopathol; 2012 May; 40(5):410-5. PubMed ID: 22508675
[TBL] [Abstract][Full Text] [Related]
14. The Impact of Noninvasive Follicular Variant of Papillary Thyroid Carcinoma on Rates of Malignancy for Fine-Needle Aspiration Diagnostic Categories.
Strickland KC; Howitt BE; Marqusee E; Alexander EK; Cibas ES; Krane JF; Barletta JA
Thyroid; 2015 Sep; 25(9):987-92. PubMed ID: 26114752
[TBL] [Abstract][Full Text] [Related]
15. Reclassifying formerly indeterminate thyroid FNAs using the Bethesda system reduces the number of inconclusive cases.
Song JY; Chu YC; Kim L; Park IS; Han JY; Kim JM
Acta Cytol; 2012; 56(2):122-9. PubMed ID: 22378073
[TBL] [Abstract][Full Text] [Related]
16. Eliminating the "Atypia of Undetermined Significance/Follicular Lesion of Undetermined Significance" category from the Bethesda System for Reporting Thyroid Cytopathology.
Singh RS; Wang HH
Am J Clin Pathol; 2011 Dec; 136(6):896-902. PubMed ID: 22095375
[TBL] [Abstract][Full Text] [Related]
17. A simplified Bethesda System for reporting thyroid cytopathology using only four categories improves intra- and inter-observer diagnostic agreement and provides non-overlapping estimates of malignancy risks.
Walts AE; Bose S; Fan X; Frishberg D; Scharre K; de Peralta-Venturina M; Zhai J; Marchevsky AM
Diagn Cytopathol; 2012 May; 40 Suppl 1():E62-8. PubMed ID: 21557534
[TBL] [Abstract][Full Text] [Related]
18. Yield of repeat fine-needle aspiration biopsy and rate of malignancy in patients with atypia or follicular lesion of undetermined significance: the impact of the Bethesda System for Reporting Thyroid Cytopathology.
Chen JC; Pace SC; Chen BA; Khiyami A; McHenry CR
Surgery; 2012 Dec; 152(6):1037-44. PubMed ID: 23040711
[TBL] [Abstract][Full Text] [Related]
19. A meta-analytic review of the Bethesda System for Reporting Thyroid Cytopathology: Has the rate of malignancy in indeterminate lesions been underestimated?
Straccia P; Rossi ED; Bizzarro T; Brunelli C; Cianfrini F; Damiani D; Fadda G
Cancer Cytopathol; 2015 Dec; 123(12):713-22. PubMed ID: 26355876
[TBL] [Abstract][Full Text] [Related]
20. Analysis of the bethesda system for reporting thyroid cytopathology and similar precursor thyroid cytopathology reporting schemes.
Wong LQ; Baloch ZW
Adv Anat Pathol; 2012 Sep; 19(5):313-9. PubMed ID: 22885380
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]